| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 2-Yr Return |
|---|---|---|---|---|---|
|
PRLB
Proto Labs
|
Jun 08, 2026 | BUY |
Buy
-16.5% avg upside
11 analysts
|
$70.00
13.57% Downside
|
· |
|
XOMA
XOMA Royalty Corporation
|
May 22, 2026 | HOLD |
Buy
-46.4% avg upside
11 analysts
|
— | +0.1% |
|
ITGR
Integer Holdings
|
Feb 20, 2026 | BUY |
Buy
+6.6% avg upside
15 analysts
|
$95.00
4.50% Upside
|
+6.6% |
|
HALO
Halozyme
|
Feb 19, 2026 | BUY |
Strong Buy
-13.7% avg upside
20 analysts
|
$90.00
31.29% Upside
|
-4.8% |
|
IL:KMDA
Kamada
|
Jan 08, 2026 | BUY |
Strong Buy
+74.5% avg upside
7 analysts
|
$4373.55
104.59% Upside
|
· |
|
LGND
Ligand Pharma
|
Dec 10, 2025 | BUY |
Strong Buy
-20.8% avg upside
15 analysts
|
$220.00
19.96% Downside
|
+43.0% |
|
CDXS
Codexis
|
Nov 14, 2025 | HOLD |
Strong Buy
+291.5% avg upside
13 analysts
|
— | +49.1% |
|
OABI
OmniAb
|
Nov 06, 2025 | BUY |
Strong Buy
+249.1% avg upside
10 analysts
|
$4.00
71.02% Upside
|
+65.2% |
|
INTS
Intensity Therapeutics, Inc.
|
Oct 31, 2025 | BUY |
Strong Buy
+1441.3% avg upside
6 analysts
|
$37.50
856.60% Upside
|
-74.6% |
|
RGEN
Repligen
|
Oct 29, 2025 | HOLD |
Strong Buy
+28.3% avg upside
25 analysts
|
— | -17.6% |
|
ABCL
AbCellera Biologics
|
Aug 13, 2025 | HOLD |
Strong Buy
+139.4% avg upside
15 analysts
|
— | -3.7% |
|
NEPH
Nephros
|
Aug 12, 2025 | BUY |
Strong Buy
+106.4% avg upside
2 analysts
|
$5.00
58.73% Upside
|
-13.6% |
|
BLFS
BioLife Solutions
|
Aug 11, 2025 | BUY |
Strong Buy
+13.0% avg upside
17 analysts
|
$30.00
15.16% Upside
|
+7.1% |
|
EBS
Emergent Biosolutions
|
Aug 08, 2025 | BUY |
Buy
+217.0% avg upside
9 analysts
|
$12.00
49.93% Upside
|
-6.7% |
|
TECH
Bio-Techne
|
Aug 07, 2025 | BUY |
Strong Buy
+38.6% avg upside
21 analysts
|
$75.00
29.43% Upside
|
+12.4% |
|
HYFT
MindWalk Holdings
|
Jul 31, 2025 | BUY |
Strong Buy
+183.2% avg upside
3 analysts
|
$3.00
96.07% Upside
|
-28.3% |
|
ANEB
Anebulo Pharmaceuticals
|
May 22, 2025 | BUY |
Buy
+796.5% avg upside
5 analysts
|
$3.00
668.48% Upside
|
-58.6% |
|
ATHE
Alterity Therapeutics
|
Feb 03, 2025 | HOLD |
Strong Buy
+68.0% avg upside
5 analysts
|
$4.00
18.08% Downside
|
-21.8% |
|
TMO
Thermo Fisher
|
Oct 26, 2023 | HOLD |
Strong Buy
+26.9% avg upside
38 analysts
|
— | +30.9% |
|
DHR
Danaher
|
Oct 25, 2023 | HOLD |
Strong Buy
+21.8% avg upside
45 analysts
|
— | +17.0% |
|
CSBR
Champions Oncology
|
Sep 15, 2023 | HOLD |
Strong Buy
+34.6% avg upside
6 analysts
|
— | +58.1% |
|
PCSA
Processa Pharmaceuticals
|
Apr 04, 2023 | BUY |
Strong Buy
+1996.9% avg upside
5 analysts
|
$80.00
3673.65% Upside
|
-96.5% |
|
FBIO
Fortress Biotech
|
Feb 24, 2021 | BUY |
Strong Buy
+163.3% avg upside
12 analysts
|
$9.00
201.02% Upside
|
-83.0% |
|
CVM
Cel-Sci
|
Jan 24, 2020 | HOLD |
Hold
2 analysts
|
— | -55.8% |
|
FEED
ENvue Medical Inc
|
Jan 09, 2019 | BUY |
Strong Buy
+1463.6% avg upside
1 analyst
|
$10.50
1463.60% Upside
|
-73.7% |
|
IDXG
Interpace Diagnostics Group
|
Oct 17, 2018 | BUY |
Strong Buy
+617.5% avg upside
9 analysts
|
$4.20
152.04% Upside
|
· |
|
NUWE
Nuwellis
|
Aug 28, 2018 | BUY |
Strong Buy
+16826.0% avg upside
7 analysts
|
$46.20
34506.71% Upside
|
-97.9% |
|
GRCE
Grace Therapeutics
|
Jan 29, 2018 | BUY |
Strong Buy
+153.0% avg upside
9 analysts
|
— | -35.0% |
|
XWEL
XWELL
|
Nov 07, 2013 | BUY |
Buy
+372.6% avg upside
4 analysts
|
$5.25
341.12% Upside
|
-88.4% |
|
AGEN
Agenus
|
Mar 12, 2013 | BUY |
Strong Buy
+165.3% avg upside
17 analysts
|
$6.00
100.08% Upside
|
+27.0% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.